AcouSort AB (publ) (STO:ACOU)
3.720
+0.170 (4.79%)
Jul 24, 2026, 4:41 PM CET
AcouSort AB Revenue
In the year 2025, AcouSort AB had annual revenue of 10.43M SEK with 4.01% growth. AcouSort AB had revenue of 2.82M in the quarter ending December 31, 2025, a decrease of -11.56%.
Revenue
10.43M
Revenue Growth
+4.01%
P/S Ratio
7.47
Revenue / Employee
913.82K
Employees
11
Market Cap
75.13M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 10.43M | 402.00K | 4.01% |
| Dec 31, 2024 | 10.03M | -521.00K | -4.94% |
| Dec 31, 2023 | 10.55M | 1.97M | 22.90% |
| Dec 31, 2022 | 8.59M | 2.63M | 44.04% |
| Dec 31, 2021 | 5.96M | -863.00K | -12.65% |
| Dec 31, 2020 | 6.82M | 3.78M | 124.37% |
| Dec 31, 2019 | 3.04M | 1.67M | 122.13% |
| Dec 31, 2018 | 1.37M | -1.23M | -47.22% |
| Dec 31, 2017 | 2.59M | -128.00K | -4.70% |
| Dec 31, 2016 | 2.72M | 1.15M | 72.83% |
| Dec 31, 2015 | 1.58M | -310.00K | -16.45% |
| Dec 31, 2014 | 1.89M | 308.63K | 19.58% |
| Dec 31, 2013 | 1.58M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Alzinova AB | 25.66M |
| Fluicell AB | 20.15M |
| Biovica International AB | 13.49M |
| Spago Nanomedical AB | 4.38M |
| 2cureX AB | 1.98M |
| Pila Pharma AB | 1.13M |
| Alligator Bioscience AB | 520.00K |
| OncoZenge AB | 71.00K |
AcouSort AB News
- 2 months ago - AcouSort AB Quarterly report: Q1 2026 - Filings
- 5 months ago - AcouSort AB Quarterly report: Q4 2025 - Filings
- 5 months ago - AcouSort AB Annual report: Q4 2025 - Filings
- 8 months ago - AcouSort AB Quarterly report: Q3 2025 - Filings
- 11 months ago - AcouSort AB Quarterly report: Q2 2025 - Filings